+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Angioedema Treatment Market Research Report by Drugs Type, Route of Administration, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 250 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4904682
UP TO OFF until Dec 31st 2022
The Global Angioedema Treatment Market size was estimated at USD 3,425.93 million in 2021, USD 4,008.36 million in 2022, and is projected to grow at a CAGR 17.17% to reach USD 8,868.50 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Angioedema Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drugs Type, the market was studied across C1 Esterase Inhibitor, Kallikrein Inhibitor, and Selective Bradykinin B2 Receptor Antagonist. The C1 Esterase Inhibitor is further studied across Berinert, Cinryze, Haegarda, and Ruconest. The Kallikrein Inhibitor is further studied across Kalbitor. The Selective Bradykinin B2 Receptor Antagonist is further studied across Firazyr.
  • Based on Route of Administration, the market was studied across Injections and Oral.
  • Based on End-User, the market was studied across Clinics, Hospitals, and Research Organizations.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Angioedema Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Angioedema Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Angioedema Treatment Market, including Adverum Biotechnologies, Inc., AMBOSS, Apotex Corp., AstraZeneca PLC, Attune Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Cipla USA Inc., CSL Behring GmbH, Dyax Corp., Fresenius Kabi USA, LLC, GlaxoSmithKline PLC, Ionis Pharmaceuticals, Inc., KalVista Pharmaceuticals, Inc., Lecturio GmbH, Merck & Co., Inc., Pharming Group N.V., Sanofi S.A, Shire Pharmaceuticals Ireland Limited, Slayback Pharma LLC, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals USA, Inc., and Viropharma Biologics Llc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Angioedema Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Angioedema Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Angioedema Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Angioedema Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Angioedema Treatment Market?
6. What is the market share of the leading vendors in the Global Angioedema Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Angioedema Treatment Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of hereditary angioedema (HAE) globally
5.1.1.2. Growing initiatives for improving awareness levels among the population
5.1.1.3. Rising incidence of genetic mutation leading to disorder
5.1.2. Restraints
5.1.2.1. Misdiagnosis of angioedema
5.1.3. Opportunities
5.1.3.1. Large population with unmet medical needs
5.1.3.2. New therapies & innovations in angioedema treatment
5.1.4. Challenges
5.1.4.1. High cost of the drugs used for treatment
5.2. Cumulative Impact of COVID-19
6. Angioedema Treatment Market, by Drugs Type
6.1. Introduction
6.2. C1 Esterase Inhibitor
6.2.1. Berinert
6.2.2. Cinryze
6.2.3. Haegarda
6.2.4. Ruconest
6.3. Kallikrein Inhibitor
6.3.1. Kalbitor
6.4. Selective Bradykinin B2 Receptor Antagonist
6.4.1. Firazyr
7. Angioedema Treatment Market, by Route of Administration
7.1. Introduction
7.2. Injections
7.3. Oral
8. Angioedema Treatment Market, by End-User
8.1. Introduction
8.2. Clinics
8.3. Hospitals
8.4. Research Organizations
9. Americas Angioedema Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Angioedema Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Angioedema Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Adverum Biotechnologies, Inc.
13.2. AMBOSS
13.3. Apotex Corp.
13.4. AstraZeneca PLC
13.5. Attune Pharmaceuticals, Inc.
13.6. BioCryst Pharmaceuticals, Inc.
13.7. Cipla USA Inc.
13.8. CSL Behring GmbH
13.9. Dyax Corp.
13.10. Fresenius Kabi USA, LLC
13.11. GlaxoSmithKline PLC
13.12. Ionis Pharmaceuticals, Inc.
13.13. KalVista Pharmaceuticals, Inc.
13.14. Lecturio GmbH
13.15. Merck & Co., Inc.
13.16. Pharming Group N.V.
13.17. Sanofi S.A
13.18. Shire Pharmaceuticals Ireland Limited
13.19. Slayback Pharma LLC
13.20. Takeda Pharmaceutical Company Limited
13.21. Teva Pharmaceuticals USA, Inc.
13.22. Viropharma Biologics Llc
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ANGIOEDEMA TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL ANGIOEDEMA TREATMENT MARKET DYNAMICS
FIGURE 8. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2027
FIGURE 11. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY C1 ESTERASE INHIBITOR, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY C1 ESTERASE INHIBITOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY BERINERT, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY BERINERT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY CINRYZE, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY CINRYZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY HAEGARDA, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY HAEGARDA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY RUCONEST, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY RUCONEST, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY KALLIKREIN INHIBITOR, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY KALLIKREIN INHIBITOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY KALBITOR, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY KALBITOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY SELECTIVE BRADYKININ B2 RECEPTOR ANTAGONIST, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY SELECTIVE BRADYKININ B2 RECEPTOR ANTAGONIST, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY FIRAZYR, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY FIRAZYR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 30. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 32. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY INJECTIONS, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY INJECTIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY ORAL, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 37. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2027
FIGURE 39. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY CLINICS, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 47. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 49. ARGENTINA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. BRAZIL ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. CANADA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. MEXICO ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 55. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 57. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 59. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 61. AUSTRALIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. CHINA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. INDIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. INDONESIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. JAPAN ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. MALAYSIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. PHILIPPINES ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. SINGAPORE ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. SOUTH KOREA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. TAIWAN ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. THAILAND ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 76. FRANCE ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. GERMANY ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. ITALY ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. NETHERLANDS ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. QATAR ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. RUSSIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. SAUDI ARABIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. SOUTH AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. SPAIN ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. UNITED ARAB EMIRATES ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. UNITED KINGDOM ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. GLOBAL ANGIOEDEMA TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 88. GLOBAL ANGIOEDEMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANGIOEDEMA TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ANGIOEDEMA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY C1 ESTERASE INHIBITOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY C1 ESTERASE INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY C1 ESTERASE INHIBITOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY C1 ESTERASE INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY C1 ESTERASE INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY BERINERT, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY BERINERT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY BERINERT, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY BERINERT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY BERINERT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY CINRYZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY CINRYZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY CINRYZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY CINRYZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY CINRYZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY HAEGARDA, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY HAEGARDA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY HAEGARDA, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY HAEGARDA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY HAEGARDA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY RUCONEST, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY RUCONEST, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY RUCONEST, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY RUCONEST, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY RUCONEST, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY KALLIKREIN INHIBITOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY KALLIKREIN INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY KALLIKREIN INHIBITOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY KALLIKREIN INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY KALLIKREIN INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY KALBITOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY KALBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY KALBITOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY KALBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY KALBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY SELECTIVE BRADYKININ B2 RECEPTOR ANTAGONIST, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY SELECTIVE BRADYKININ B2 RECEPTOR ANTAGONIST, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY SELECTIVE BRADYKININ B2 RECEPTOR ANTAGONIST, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY SELECTIVE BRADYKININ B2 RECEPTOR ANTAGONIST, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY SELECTIVE BRADYKININ B2 RECEPTOR ANTAGONIST, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY FIRAZYR, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY FIRAZYR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY FIRAZYR, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY FIRAZYR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY FIRAZYR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY INJECTIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY INJECTIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY INJECTIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY INJECTIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY INJECTIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY ORAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 63. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 64. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 66. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 69. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 71. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. GLOBAL ANGIOEDEMA TREATMENT MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 81. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 82. AMERICAS ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 83. ARGENTINA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. ARGENTINA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 85. ARGENTINA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 86. ARGENTINA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 87. BRAZIL ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. BRAZIL ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 89. BRAZIL ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 90. BRAZIL ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 91. CANADA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. CANADA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 93. CANADA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 94. CANADA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 95. MEXICO ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. MEXICO ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 97. MEXICO ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 98. MEXICO ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 99. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 101. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 102. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 103. UNITED STATES ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 104. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 107. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 108. ASIA-PACIFIC ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 109. AUSTRALIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. AUSTRALIA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 111. AUSTRALIA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 112. AUSTRALIA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 113. CHINA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. CHINA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 115. CHINA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 116. CHINA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 117. INDIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. INDIA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 119. INDIA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 120. INDIA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 121. INDONESIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 122. INDONESIA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 123. INDONESIA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 124. INDONESIA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 125. JAPAN ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. JAPAN ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 127. JAPAN ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 128. JAPAN ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 129. MALAYSIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 130. MALAYSIA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 131. MALAYSIA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 132. MALAYSIA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 133. PHILIPPINES ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. PHILIPPINES ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 135. PHILIPPINES ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 136. PHILIPPINES ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 137. SINGAPORE ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. SINGAPORE ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 139. SINGAPORE ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 140. SINGAPORE ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 141. SOUTH KOREA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 142. SOUTH KOREA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 143. SOUTH KOREA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 144. SOUTH KOREA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 145. TAIWAN ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. TAIWAN ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 147. TAIWAN ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 148. TAIWAN ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 149. THAILAND ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 150. THAILAND ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 151. THAILAND ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 152. THAILAND ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 158. FRANCE ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 159. FRANCE ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 160. FRANCE ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 161. FRANCE ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 162. GERMANY ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. GERMANY ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 164. GERMANY ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 165. GERMANY ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 166. ITALY ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 167. ITALY ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 168. ITALY ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 169. ITALY ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 170. NETHERLANDS ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 171. NETHERLANDS ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 172. NETHERLANDS ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 173. NETHERLANDS ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 174. QATAR ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 175. QATAR ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 176. QATAR ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 177. QATAR ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 178. RUSSIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. RUSSIA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 180. RUSSIA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 181. RUSSIA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 182. SAUDI ARABIA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 183. SAUDI ARABIA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 184. SAUDI ARABIA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 185. SAUDI ARABIA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 186. SOUTH AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 187. SOUTH AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 188. SOUTH AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 189. SOUTH AFRICA ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 190. SPAIN ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 191. SPAIN ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 192. SPAIN ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 193. SPAIN ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 198. UNITED KINGDOM ANGIOEDEMA TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 199. UNITED KINGDOM ANGIOEDEMA TREATMENT MARKET SIZE, BY DRUGS TYPE, 2019-2027 (USD MILLION)
TABLE 200. UNITED KINGDOM ANGIOEDEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 201. UNITED KINGDOM ANGIOEDEMA TREATMENT MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 202. GLOBAL ANGIOEDEMA TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 203. GLOBAL ANGIOEDEMA TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 204. GLOBAL ANGIOEDEMA TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 205. GLOBAL ANGIOEDEMA TREATMENT MARKET RANKING
TABLE 206. GLOBAL ANGIOEDEMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 207. GLOBAL ANGIOEDEMA TREATMENT MARKET MERGER & ACQUISITION
TABLE 208. GLOBAL ANGIOEDEMA TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 209. GLOBAL ANGIOEDEMA TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 210. GLOBAL ANGIOEDEMA TREATMENT MARKET INVESTMENT & FUNDING
TABLE 211. GLOBAL ANGIOEDEMA TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 212. GLOBAL ANGIOEDEMA TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Adverum Biotechnologies, Inc.
  • AMBOSS
  • Apotex Corp.
  • AstraZeneca PLC
  • Attune Pharmaceuticals, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Cipla USA Inc.
  • CSL Behring GmbH
  • Dyax Corp.
  • Fresenius Kabi USA, LLC
  • GlaxoSmithKline PLC
  • Ionis Pharmaceuticals, Inc.
  • KalVista Pharmaceuticals, Inc.
  • Lecturio GmbH
  • Merck & Co., Inc.
  • Pharming Group N.V.
  • Sanofi S.A
  • Shire Pharmaceuticals Ireland Limited
  • Slayback Pharma LLC
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceuticals USA, Inc.
  • Viropharma Biologics Llc

Methodology

Loading
LOADING...